KRAS and neoplasm: Gene ontology (GO) analysis of the Cluster 13 signature revealed a significant enrichment in epithelial-to-mesenchymal transition (EMT) and KRAS signaling gene sets (Fig. 3A) suggesting that Cluster 13 cells have more aggressive metastatic potential compared to non-Cluster 13 cells within the same tumor.